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Summary 
CD8 + T cells taken directly from mice expressing  a Kb-specific T cell receptor (TCR) transgene 
expressed the transgenic TCR in a bimodal profile as detected by flow cytometric analysis using 
a clonotype-specific monoclonal antibody. Those cells expressing the lower density of the transgenic 
TCR expressed the transgenic 3 chain and two different oe chains on their surface. One ol chain 
was the product of the c~ transgene, whereas the other was derived by endogenous rearrangement. 
This report provides the first demonstration that T cells isolated directly from mice may express 
two different TCR clonotypes on their surface. The potential consequences  of this finding for 
studies using TCR transgenic mice and for the induction of autoimmunity are discussed. 
T  cell development involves several important processes in- 
cluding rearrangement of the TCR genes, positive se- 
lection for MHC restriction, and negative selection against 
autoreactive clones (1). Rearrangement of the c~ and 3 chains 
of the TCR is critical in the generation of a diverse T  cell 
repertoire (2).  Current evidence  suggests that the 3  chain 
alleles are the first  to rearrange and do so sequentially (3). 
Once a productive rearrangement is achieved,  further rear- 
rangement is allelicaUy excluded (4, 5). By contrast, oe chain 
rearrangement,  which is less well understood, may occur 
simultaneously (6) and continue to do so until a positive se- 
lection signal is received (7). The less stringent allelic exclu- 
sion of the oe chain may account for the finding that some 
T  cell clones express  two different c~ chains (1,  6). 
In this report, we raise the issue of multiple ot chain ex- 
pression by TCR transgenic T cells. Evidence is provided for 
the in vivo presence  of T  cells expressing two different c~ 
chains on their surface. This finding has important implica- 
tions for experimental systems that utilize TCR transgenic 
mice. 
Materials and Methods 
Mice.  B10.BR  and transgenic mice were bred at the Walter and 
Eliza Hall Institute for Medical Research. RIP-K  b mice were de- 
rived as previously described (8) and were maintained by mating 
with H-2  k CBA/CaHWehi mice. Des-TCR transgenic mice were 
the kind gift ofDrs. B. Arnold, G. Sch6nrich and G. J. H~mmer- 
ling (Deutsches Krebsforschungszentrum, Heidelberg, Germany), 
and were derived as previously described (9). The Des-TCR line 
was maintained by mating with H-2  k B10.BR mice. 
Antibodies.  The D6sir6 mAb was the kind gift of Dr. A.-M. 
Schmitt-Verhulst (Centre d'Immtmologie  de Marseille-Luminy,  Mar- 
seilh, France) (10). PE- and FITC-conjugated  CD8 mAbs were pur- 
chased from Becton Dickinson and Co., Mountain View, CA. V 
region-speeific mAbs B20.1 (anti-V~2) and B20.6 (anti-Va2) were 
the kind gift of  Dr. R Malissen (Centre d'Immunologie de Marseille- 
Luminy) (11). RR3-15 (anti-V~11) (12) and KT50 (anti-V~8) (13) 
mAbs were used as biotinylated mAbs. The GK1.5 mAb was used 
for staining CD4 + cells (14). FITC-conjugated sheep anti-mouse 
Ig was purchased from Silenus Laboratories  Pty. Ltd., Hawthorn, 
Australia. 
Flow Cytometry.  Two different methods of staining were used. 
All incubations were performed on ice in the dark. When cells 
were stained with only two different mAbs, 5  x  10  s cells were 
stained with CD8-FITC and the appropriate biotinylated mAb for 
30 rain. After two washes, cells  were then stained  with streptavidin- 
PE (Caltag Labs., S. San Francisco,  CA) for a further 30 rain, washed 
once, and analyzed. 
When cells were stained with three different mAbs, 5  x  10  s 
cells were stained with the appropriate mAb (B20.1, B20.6, or 
GK1.5) for 30 rain. After two washes, cells were stained with sheep 
anti-mouse Ig for 30 rain. Cells were then washed twice and ex- 
posed to 20/~1 of rat serum for 15 min to block any vacant mouse 
Ig binding sites on sheep antibodies. This was followed  by staining 
with the appropriate biotinylated TCR-specific mAb (B20.1 or 
D6sir6) and CDS-PE for 30 min, two washes, and staining with 
streptavidin conjugated to Tri-color (Caltag Labs.) for 30 rain. After 
one further wash, cells were analyzed by flow cytometry. 
Analysis was performed on a FACScan  |  (Becton Dickinson and 
Co.). Live  gates were set on lymphocytes  by forward and side scatter 
profiles. Live  gates were also set on CD8 § cells, and 10,000 cells 
were analyzed. 
Results and Discussion 
Identification of  Bimodal Expression of  a ~ansgenic TCR.  We 
have been interested in addressing the fate of T ceUs that are 
specific for antigens expressed outside the thymus. For these 
studies, we have used the RIP-K  b model in which transgenic 
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Figure  1.  Expression of the Des-TCK by CD8 + lymph node cells from 
Des-TCR and Des-TCR  x  KIP-K  b transgenic  mice. Lymph  node cells 
from (A) Des-TCK and (B) Des-TCK  x  KIP-K  b transgenic  mice were 
stained for CD8 and Des-TCK expression and analyzed by flow cytometry. 
mice express the class I  molecule K b in the/3 cells of the 
pancreas,  under the control of the rat insulin promoter (8). 
To examine the fate of Kb-specific T  cells in KIP-K  b mice, 
these mice were crossed with TCR transgenic mice (Des- 
TCK mice) that expressed a transgene encoding a Kb-specific 
TCK. This receptor could be detected by the clonotype-specific 
mAb D6sir6  (10). Flow cytometric analysis of lymph node 
CD8 + T cells revealed that both single Des-TCK transgenic 
mice and double Des-TCR  x  KIP-K  b transgenic mice had 
KLspecific T  cells in their periphery (Fig.  1 and reference 
15). Of note, however, was the significant reduction in the 
number of cells expressing the highest density of the Des- 
TCK in the double transgenic mice. These analyses high- 
lighted the fact that the CD8 + T  cells in the periphery of 
Des-TCK mice expressed variable levels of the donotypic Des- 
TCR characterized by a bimodal profile of low and high TCR 
densities. Des-TCK mice were analyzed on numerous occa- 
sions  and the bimodal expression was highly reproducible, 
although the proportion of CD8 + cells that comprised each 
peak was variable. 
CD8 + T  Cells Expressing  the Lower Density  of Des-TCR 
Express the Transgenic cr Chain.  One explanation for the bi- 
modal expression of the Des-TCK in single transgenic mice 
was that some cells expressed an endogenous o~ chain, rather 
than the transgenic c~ chain, paired with the transgenic/3 
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Figure  3.  CD3 is expressed as a single peak by CD8 + lymph node cells 
from Des-TCR transgenic  mice. Lymph node cells from Des-TCK trans- 
genic mice were stained for the expression of CD8 and either (A) the Des- 
TCR or (B) CD3, and analyzed by flow cytometry. Histograms show Des- 
TCK or CD3 expression by CD8 + cells from Des-TCR transgenic mice 
(solid lines)￿9  As a negative  control,  V~11 expression  by CD8 + cells is 
shown (dotted lines). 
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chain. Together these chains may form a new TCK detected 
with lower affinity by the D6sir6 mAb. To test this, lymph 
node cells from a Des-TCK mouse were double stained for 
CD8 and V~2 expression, the latter being the V~ expressed 
by the transgene (Fig. 2). Virtually all CD8 + cells expressed 
the V~2 transgene, and this was expressed with a similar bi- 
modal profile as seen for the Des-TCK. This suggested that 
those transgenic CD8 + cells expressing the lower density of 
the Des-TCR also expressed a low density of the transgenic 
o~ chain. 
CD8 + T  Cells from Des-TCR Mice Do Not Show Bimoclal 
Expression of CD3 and the Transgenic /3 Chain.  An alterna- 
tive possibility was that calls expressing the lower density 
of the Des-TCK might express two different receptors, only 
one of which could be identified by the D6sir6 mAb. To ex- 
amine this possibility,  Des-TCK transgenic lymph node cells 
were double stained for CD3 and CD8 (Fig. 3). This revealed 
that in contrast to Des-TCK expression, CD3 was expressed 
as a single peak by lymph node CD8 + T cells. To determine 
whether the transgenic CD8 + T  cells expressed the trans- 
genic/3 chain as a single or double peak, Des-TCK lymph 
node cells were stained for CD8 and for the transgenic/3 
chain V~2 (Fig.  4). In this case, a biotinylated Vt~2-spedfic 
mAb was not available, requiring an alternative staining ap- 
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Figure  2.  V,~2  is expressed in a bimodal manner by CD8 + lymph node 
cells from Des-TCK  transgenic  mice. Lymph node cells from Des-TCR 
transgenic mice were double stained for the expression of CD8 and either 
(A) the Des-TCK or (/3) Va2, and analyzed by flow cytometry (solid lines). 
As a negative control, Vflll expression by CD8 + cells is shown (dotted 
lines). 
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Figure 4.  V~2 is expressed  as a single  peak by CD8 + lymph node cells 
from Des-TCK transgenic  mice. Lymph  node cells from Des-TCR trans- 
genie mice were stained for CD8 and either (A) V,~2 or (/3) Va2, and 
analyzed  by flow  cytometry  (solid lines). As a negative  control, cells  stained 
with all antibodies except  the primary  V region-specific  mAb are shown 
(dotted lines). 
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Figure 5.  V~8 is expressed by a subpopulation of Des-TCK+CD8 + 
lymph node cells from Des-TCR transgenic mice. Lymph node cells from 
Des-TCR transgenic mice were triple stained for CD8, Des-TCR, and ei- 
ther (A) Va8 or (B) V~11, and analyzed by flow cytometry. Contour plots 
show expression of Des-TCR  and either V~8 or V~11 by CD8 + cells. 
proach. Thus, while control staining for V,2 showed a bi- 
modal peak, it was not as dearly revealed as in Fig. 2. It is, 
however, evident that the profile of expression of Va2 is a 
single peak, as seen for CD3. Thus, CD3 and the Vt~2 trans- 
gene were expressed as a single peak, whereas the clonotypic 
receptor and the V,~2 transgene were expressed in a bimodal 
manner. 
Des-TCR Density Variation Is Due to the Expression of Two 
ot Chains by Some CD8 + T  Cells.  These results suggested 
that those cells expressing the lower density of the Des-TCR 
in the Des-TCR transgenic mice may represent cells expressing 
the transgenic B chain and two c~ chains: one being the trans- 
genic c~ chain and the other endogenously rearranged. To 
test this possibility, Des-TCR transgenic lymph node cells 
were triple stained for CD8,  the Des-TCR,  and V~8 (Fig. 
5).  Staining for V~8  was of low intensity, but in control 
B10.BR  mice this method identified a percentage of cells 
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Figure 6.  CD8+V~8 + T cells from Des-TCR transgenic mice express 
the lower density of the Des-TCR. Lymph node cells from Des-TCK trans- 
genic mice  were  stained  as in Fig.  5  and CD8 +  cells (solid  line)  or 
CDS+Va8 + cells (dotted line)  were examined for their expression of the 
Des-TCK. For convenience of comparison, the profile of V,~8  + cells has 
been magnified relative to the unseparated population. V~8 + cells  repre- 
sent 4.9% of the unseparated population. 
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Figure 7.  Both V~8 and Va2 are expressed by some CD8 + T cells from 
Des-TCR transgenic mice. Lymph node cells from Des-TCR transgenic 
mice were triple stained for CD8, V,8, and either (.4) the Des-TCR or 
(B) V,2, and analyzed by flow cytometry.  Contour plots show expres- 
sion of V,~8 and either Des-TCR  or Va2 by CD8 + cells. 
similar to that previously published (13) (data not shown). 
Importantly, Des-TCR mice showed a small percentage of 
CD8+Des-TCR + cells that expressed V~8.  In five experi- 
ments, an average of 4.1  _+ 0.8% ofCDS+Des-TCR + cells 
expressed V~8. When the CD8 +  V~8 + cells were examined 
for Des-TCR expression, these cells were found to be included 
in the population of cells expressing the lower density of the 
Des-TCR (Fig. 6). Furthermore, the mean intensity of V~8 
on Des-TCK + cells was found to be half that  of normal 
B10.BR cells (mean fluorescence intensity of 41.5 vs. 84.2). 
Triple staining for CD8,  V~2 and V~8 revealed that some 
cells expressed both V~2 and V~8 (Fig.  7).  Together these 
data showed that Des-TCR transgenic mice possess CD8 + 
T  cells that express different densities of the Des-TCR,  of 
which at least some of those expressing the lower density 
also express an endogenous ot chain on their surface. 
Potential Consequences of the Expression of Two cr Chains.  To 
our knowledge, this finding represents the first demonstra- 
tion that in vivo cells can express two different types of TCK 
on the surface of the same cell. Whether such cells are also 
present in normal T cell repertoires must await further anal- 
ysis. These findings have extremely important implications 
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when addressing the various haplotypes that positively select 
a given TCR transgene, the endogenous expression of an ot 
chain together with the transgenic o~ chain could lead to false 
conclusions. In situations where the transgenic receptor cannot 
receive a positive selection signal, T  cells may be positively 
selected by their nontransgenic receptor. T cells bearing the 
transgenic receptor would enter the periphery of these mice, 
leading to the false conclusion that positive selection had oc- 
curred via this receptor. 
The second, and more major consequence of expressing 
two c~ chains is that such T cells may have two completely 
different antigen specificities. This is particularly relevant to 
autoimmunity studies.  We recently reported the induction 
of autoimmune diabetes in transgenic mice coexpressing three 
different transgenes, the Des-TCR,  RIP-K  b, and KIP-IL-2 
(IL-2 expressed by the pancreatic/3 cells) (15). In some mice, 
diabetes was induced as early as 7 d  after birth.  Since the 
CD8 + T  cells in these triple transgenic mice expressed the 
lower density of the Des-TCR, due to the thymic deletion 
of those cells expressing the higher density (15), it is likely 
that they also expressed a second TCK comprised of the trans- 
genic/3 chain and an endogenous ot chain. Since naive T cells 
do not express  IL-2 receptors, and do not usually infiltrate 
tissues  (16), it was unclear how these Kb-specific cells were 
initially activated so that they could respond to IL-2 and de- 
stroy islet tissue. How they were attracted to the islets without 
expressing IL-2 receptors is still unresolved. While it is pos- 
sible that these cells were attracted by secondary lymphokines 
induced as a consequence of IL-2 synthesis, the likely expres- 
sion of two receptors raises an alternative possibility. These 
cells may have been activated via recognition of an environ- 
mental antigen by their endogenously derived TCR and, after 
activation, responded to IL-2 produced by the islet/3 cells 
and caused Kb-specific destruction via their transgenic TCR. 
This scenario may be applicable  to several other models. 
Recently, aft transgenic nonobese diabetic mice were shown 
to be susceptible to autoimmune diabetes despite their ex- 
pression of a transgenic TCK with no specificity for islet an- 
tigens (17). In this study, the expression of endogenously rear- 
ranged ot chains was not examined. Such c~ chains may have 
combined with the transgenic/3 chain to produce a broad 
repertoire still  capable  of causing specific autoimmunity. 
It has also been reported that TCR transgenic mice specific 
for myelin basic protein developed spontaneous autoimmu- 
nity, but that this varied depending on the animal housing 
facility (18). This might be explained if two receptors were 
expressed by the transgenic T cells. Once these cells responded 
to an environmental antigen via their endogenously rearranged 
TCK, they may have caused autoimmunity via their trans- 
genic TCK.  This would explain why animal facilities pos- 
sessing a greater number of pathogens were more likely to 
be associated  with autoimmunity. 
Relevance to Autoimmunity.  These findings question the 
view that stimulation by a cross-reactive environmental an- 
tigen is required for the induction of autoimmunity. Anal- 
ysis of T  cell clones has revealed that T  cells from normal 
repertoires can express two productively rearranged ~ chains 
(3).  In these examples,  however, only one o~ chain was de- 
tected on the cell surface. Due to the low frequency of any 
one o~ chain in a normal repertoire, and the limited range 
of ol chain-specific mAbs available, demonstration of cells 
expressing two c~ chains on their surface is technically difficult. 
If a certain proportion of T cells do express two rearranged 
c~ chains on their surface, it is possible that T cells bearing 
autoreactive TCR may be activated to cause autoimmunity 
via recognition of an environmental antigen by their second, 
nonautoreactive TCK.  In this case, no molecular mimicry 
would be required. The frequency of such cells among T cells 
bearing two different TCK is, however, likely to be very low. 
Since, of the two TCK, the autoreactive receptor would, by 
definition, be MHC restricted, there would be no require- 
ment for MHC restriction of the second receptor; positive 
selection in  the thymus could occur via  the autoreactive 
receptor. The likelihood that the second receptor would recog- 
nize an environmental antigen in an MHC-restricted manner 
would, therefore, depend on the innate frequency of MHC- 
restriction of TCRs. This might be increased somewhat by 
the presence ofa fl chain that is able to form an MHC-restricted 
receptor. 
While it remains unclear whether the presence of T cells 
expressing two TCK clonotypes is applicable  to a normal 
T cell repertoire, we have provided direct evidence that trans- 
genic T cells may possess this phenotype in vivo. Future ex- 
periments may clarify the importance of this finding to au- 
toimmunity. 
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